Search Results for the EPA National Library Catalog

Items Found: 50

Showing: Items 1 - 50

Your Search: (SUBJECT=Antineoplastic agents)

 
 
 

Select Item Title Year Published
Alleviation of Lake Pollution by Utilization of Aquatic Plants for Nutritional, Medicinal or Industrial Purposes. 1973
Anticancer drug research 1987
Antineoplastic agents 1984
Antitumor natural products basic and clinical research / 1989
Aquatic Plants from Minnesota. Part II. Toxicity, Anti-Neoplastic, and Coagulant Effects. 1972
Basis for cancer management 1996
Bioassay of 3,3'-iminobis-1-propanol dimethanesulfonate (ester) hydrochloride (IPD) for possible carcinogenicity. 1978
Bioassay of 5-azacytidine for possible carcinogenicity. 1978
Bioassay of beta-2'-deoxy-6-thioguanosine monohydrate for possible carcinogenicity. 1978
Bioassay of estradiol mustard for possible carcinogenicity. 1978
Bioassay of ICRF-159 for possible carcinogenicity. 1978
Bioassay of isophosphamide for possible carcinogenicity. 1977
Bioassay of phenesterin for possible carcinogenicity. 1978
Bioassay of thio-TEPA for possible carcinogenicity. 1978
Biological response modifiers 1983
Biological response modifiers, leukaemias and lymphomas 1987
Characterization of Air Particulate Material for Polycyclic Aromatic Compounds. 1983
Chemotherapy 1977
Chlorinated Compounds Found in Waste-Treatment Effluents and Their Capacity to Bioaccumulate. 1976
Computer-Automated Structure Evaluation of Antileukemic 9-Anilinoacridines. 1987
Concept of Activity Profiles of Antimutagens. 1989
Consideration of Pharmacokinetics and Temporal Sensitivity for Hydroxyurea in Relation to Teratogenic Potential. 1991
Diesel Emissions Symposium proceedings / 1982
DNA Adducts of the Antitumor Agent Diaziquone. 1992
Effect of Chemotherapy on the In vivo Frequency of Glycophorin A 'Null' Variant Erythrocytes (Revised). 1990
Effect of Dibutylnitrosamine and Saccharin on Glutamyl Transpeptidase-Positive Foci and Liver Cancer. 1983
Efficient Multiple-Exposure Analysis of the Toxicity of Crisnatol: A DNA Intercalator in Phase 2 Clinical Trials. 1992
Evaluation of the potential carcinogenicity of lead and lead compounds : in support of reportable quantity adjustments pursuant to CERCLA section 102. 1989
Experimental evaluation of antitumor drugs in the USA and USSR and clinical correlations 1981
Identification of selected Federal activities directed to chemicals of near-term concern : benzene, bis(chloromethyl) ether, cadmium, hydrogen sulfide, mercury, platinum, polynuclear aromatic hydrocarbons, trichloroethylene, tris(2, 3-dibromopropyl), phosphate / 1976
Induction, Accumulation, and Persistence of Sister Chromatid Exchanges in Women with Breast Cancer Receiving Cyclophosphamide, Adriamycin, and 5-Fluorouracil Chemotherapy. 1990
Inhibition of carcinogenesis 1971
Inhibition of tumor induction and development 1981
Laboratory decontamination and destruction of carcinogens in laboratory wastes : some antineoplastic agents / 1985
Limitations of the Fluorescent Probe Viability Assay. 1989
Manganese Chloride Enhances Murine Cell-Mediated Cytotoxicity: Effects on Natural Killer Cells. 1984
Modifiers of chemical carcinogenesis an approach to the biochemical mechanism and cancer prevention / 1980
Molecular and cellular biology of multidrug resistance in tumor cells 1991
Molecular cancer therapeutics. 2001
Monetizing the Pharmacological Benefits of Plants. 1991
Persistence of SCE (Sister Chromatid Exchange)-Inducing Lesions in Lymphocytes of Mice Exposed to Diaziquone (Journal Version). 1988
Principles of chemoprevention 1996
Prolonged Survival of Female AKR Mice Fed Diets Supplemented with Methionine and Choline. 1990
Some antineoplastic and immunosuppressive agents. 1981
Some antiviral and antineoplastic drugs, and other pharmaceutical agents. 2000
Structure-activity relationships of anti-tumour agents 1983
Theoretical foundations of cancer chemotherapy introduced by computer models 1992
Utility of the Murine Erythroleukemic Cell (MELC) in Assessing Mechanisms of Action of DNA-Active Developmental Toxicants: Application to 5-Fluorouracil. 1993
Waiting for treatment : timely equitable access to drugs for metastatic breast cancer / 2015
Working group on molecular mechanisms of carcinogenic and antitumor activity, October 21-25, 1986 1987

Save, Print or Email Selected Records